HomeGERN • NASDAQ
add
Geron Corp
Previous close
$3.93
Day range
$3.68 - $3.95
Year range
$1.64 - $4.30
Market cap
2.21B USD
Avg Volume
10.90M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 304.00K | 1,347.62% |
Operating expense | 56.44M | 337.71% |
Net income | -55.39M | -45.30% |
Net profit margin | -18.22K | 89.96% |
Earnings per share | -0.09 | -28.57% |
EBITDA | -56.02M | -40.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 444.17M | 16.66% |
Total assets | 482.07M | 13.46% |
Total liabilities | 137.21M | 38.84% |
Total equity | 344.87M | — |
Shares outstanding | 603.49M | — |
Price to book | 6.89 | — |
Return on assets | -32.03% | — |
Return on capital | -41.35% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -55.39M | -45.30% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Geron Corporation is a biotechnology company located in Foster City, California owned by Geron Hyn Baja of the Philippines, which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
Founded
1990
Headquarters
Website
Employees
141